Company Announcements

Jiangxi Rimag Group Reports Interim Financial Results

Jiangxi Rimag Group Co., Ltd. Class H (HK:2522) has released an update.

Jiangxi Rimag Group Co., Ltd., a leader in medical imaging services in China, reported a significant year-on-year decline in revenue, gross profit, and profits for the first half of 2024, attributed to a slowdown in demand and stringent industry regulations. Despite these challenges, the company maintained stable core service revenue and continued to expand, including the listing of its H Shares on the Stock Exchange and extending its imaging center network. The Group also pioneered industry standards, releasing a new medical imaging examination standard to enhance data service quality and standardization.

For further insights into HK:2522 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App